MBD is committed to provide better life and effective therapeutic method to patient by testing cancer drugs or radiation doses used in Neoadjuvant chemotherapy & Chemoradiotherapy through three-dimension drug sensitivity testing in head and neck cancer, esophageal cancer, breast cancer, ovarian cancer, gastric cancer, and colorectal cancer types.

MBD is conducting a precision medicine platform study to predict the responsiveness of various cancer drugs of each carcinoma using 3D cancer tissue culture to provide effective anti-cancer drugs to the patient through genome analysis and statistical interpretation of self-accumulated clinical results.

Neoadjuvant chemotherapy :

Chemotherapy before surgery. It is widely used to reduce the size of the tissue before the surgery to minimize the removal area of the tissue.

Chemoradiotherapy :

Chemotherapy is performed before or after surgery or radiation therapy for head and neck cancer, lung cancer, bladder cancer and cervical cancer. Combination of chemotherapy and radiation therapy is to amplify the radiation effect through chemotherapy and to prevent metastasis.